SCHEMBL8307276

SCHEMBL8307276

c1cc2c(c(N3CCN(CC4CCc5sccc5C4)CC3)c1)OCCO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307272 0.82 DRD2 (0.37)
SCHEMBL8306513 0.82 DRD2 (0.37)
SCHEMBL9179406 0.81 HTR1A (0.67)
SCHEMBL9038014 0.75 HTR2C (0.41)
SCHEMBL9174181 0.73
SCHEMBL9178367 0.72 ALDH1A1 (0.64)
SCHEMBL9182190 0.71 HTR1A (0.60)
SCHEMBL13499602 0.71 ADRB1 (0.67)
SCHEMBL31051847 0.71 ADRB1 (0.67)
SCHEMBL6194727 0.71 ALDH1A1 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0574313-B1 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders ADIR (FR) 1999-10-06 EP disclosed
EP-0574313-A1 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders ADIR ET COMPAGNIE (FR) 1993-12-15 EP disclosed